Bronchogen Peptide

🧪 Bronchogen Peptide – Pulmonary Research Bioregulator

🔬 Product Overview

Bronchogen is a synthetic tetrapeptide composed of the amino acid sequence Alanine-Glutamic Acid-Aspartic Acid-Leucine (AEDL). Positioned as a premier compound in pulmonary bioregulation research, Bronchogen is extensively studied for its role in modulating gene expression within the bronchial epithelium. This short-chain peptide is engineered to facilitate investigations into cellular longevity and the restoration of functional integrity in lung tissue models.

By leveraging the AEDL sequence, researchers can explore the epigenetic influence of synthetic peptides on DNA-protein interactions, specifically focusing on the regulation of inflammatory markers and cellular signaling in respiratory systems.

🧬 Mechanism of Action

The Bronchogen (AEDL) peptide is recognized for its high bioavailability and its ability to penetrate the cell nucleus, where it interacts with specific DNA strands to modulate genetic pathways.

Research suggests the AEDL sequence may:

• Modulate Epithelial Gene Expression: Studies indicate Bronchogen influences the transcriptional activity of genes associated with the bronchial mucosa.
• Regulate Inflammatory Cytokines: Investigations focus on its potential to downregulate pro-inflammatory markers (such as IL-6) in pulmonary cell models.
• Promote Cellular Homeostasis: Research explores how the peptide supports the restoration of protein synthesis in senescent or damaged lung cells.
• Enhance Ciliary Activity: Observations in tissue models suggest a role in maintaining the structural and functional dynamics of the respiratory epithelium.

📊 Research Applications

🧬 Respiratory Bioregulation & Longevity

• Studies on the reversal of age-related functional decline in pulmonary tissues.
• Investigation into the peptide’s role in tissue regeneration post-oxidative stress.
• Analysis of its efficacy in maintaining epithelial barrier integrity.

🧪 Cellular Signaling & Epigenetics

• Research into DNA-peptide interactions and chromosome "unfolding" in lung cells.
• Comparative analysis of AEDL sequences in modulating mitochondrial function.
• In vitro studies on mRNA expression levels in bronchial epithelial cultures.

⚗️ Advanced Laboratory Integration

• Synergistic research involving Bronchogen and other organ-specific bioregulators.
• Pharmacokinetic analysis of the stability of short-chain tetrapeptides.
• Comparative modeling of synthetic AEDL vs. endogenous signaling molecules.

⚗️ Product Specifications

• Product Name: Bronchogen
• Sequence: Ala-Glu-Asp-Leu (AEDL)
• Molecular Formula: C18H30N4O9
• Form: Lyophilized (freeze-dried) white powder
• Purity: Research grade (≥98% via HPLC analysis)
• Molar Mass: 446.45 g/mol
• Source: High-precision synthetic manufacture

📦 Storage & Handling

• Long-term Stability: Store at -20°C or below (lyophilized state) to prevent peptide degradation.
• Reconstitution: Use sterile laboratory-grade bacteriostatic water or PBS (Phosphate Buffered Saline).
• Post-Reconstitution: Refrigerate at 2°C to 8°C and use within 7-10 days for optimal research integrity.
• Protection: Keep away from direct UV light and avoid vigorous mechanical agitation.

🧪 Synthesis & Quality Assurance

Our Bronchogen (AEDL) is synthesized using state-of-the-art Solid-Phase Peptide Synthesis (SPPS) protocols. Each batch undergoes rigorous testing, including Mass Spectrometry (MS) and High-Performance Liquid Chromatography (HPLC), to ensure the highest standards for laboratory research and experimental validation.

Disclaimer: This compound is intended for laboratory research purposes only. It is not for human consumption, medical, or therapeutic use. Not FDA approved.